Literature DB >> 20050859

The continuum of growth hormone-IGF-I axis defects causing short stature: diagnostic and therapeutic challenges.

Martin O Savage1, Christine P Burren, Ron G Rosenfeld.   

Abstract

The growth hormone (GH)-IGF-I axis is essential for normal foetal and childhood growth. Defects at different sites in the axis frequently result in short stature which may compromise adult height. We describe a continuum of clinically relevant abnormalities from GH deficiency through to GH resistance and discuss the implementation and interpretation of investigations. We consider appropriate therapy for patients with abnormal auxology and subnormal adult height prognosis, highlighting new data to clarify therapeutic choices leading to optimal clinical outcome.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20050859     DOI: 10.1111/j.1365-2265.2009.03775.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  29 in total

1.  Effect of Growth Hormone Therapy on Height Velocity in Korean Children with Idiopathic Short Stature: A Phase III Randomised Controlled Trial.

Authors:  Woo Yeong Chung; Han-Wook Yoo; Jin Soon Hwang; Cheol Woo Ko; Ho-Seong Kim; Dong-Kyu Jin; Kee-Hyoung Lee; Heon-Seok Han; Premila Paranchothy; Byung-Kyu Suh
Journal:  Horm Res Paediatr       Date:  2018-08-15       Impact factor: 2.852

Review 2.  Nonclassical GH Insensitivity: Characterization of Mild Abnormalities of GH Action.

Authors:  Helen L Storr; Sumana Chatterjee; Louise A Metherell; Corinne Foley; Ron G Rosenfeld; Philippe F Backeljauw; Andrew Dauber; Martin O Savage; Vivian Hwa
Journal:  Endocr Rev       Date:  2019-04-01       Impact factor: 19.871

3.  IGF2 stimulates fetal growth in a sex- and organ-dependent manner.

Authors:  Veronica White; Alicia Jawerbaum; Maria Belen Mazzucco; Martin Gauster; Gernot Desoye; Ursula Hiden
Journal:  Pediatr Res       Date:  2017-10-18       Impact factor: 3.756

Review 4.  Growth hormone treatment for growth hormone deficiency and idiopathic short stature: new guidelines shaped by the presence and absence of evidence.

Authors:  Adda Grimberg; David B Allen
Journal:  Curr Opin Pediatr       Date:  2017-08       Impact factor: 2.856

5.  Large-scale analysis of variation in the insulin-like growth factor family in humans reveals rare disease links and common polymorphisms.

Authors:  Peter Rotwein
Journal:  J Biol Chem       Date:  2017-04-07       Impact factor: 5.157

Review 6.  The growth hormone receptor: mechanism of activation and clinical implications.

Authors:  Andrew J Brooks; Michael J Waters
Journal:  Nat Rev Endocrinol       Date:  2010-07-27       Impact factor: 43.330

7.  Dwarfism and increased adiposity in the gh1 mutant zebrafish vizzini.

Authors:  Sarah K McMenamin; James E N Minchin; Tiffany N Gordon; John F Rawls; David M Parichy
Journal:  Endocrinology       Date:  2013-03-01       Impact factor: 4.736

8.  Genetic evidence that thyroid hormone is indispensable for prepubertal insulin-like growth factor-I expression and bone acquisition in mice.

Authors:  Weirong Xing; Kristen E Govoni; Leah Rae Donahue; Chandrasekhar Kesavan; Jon Wergedal; Carlin Long; J H Duncan Bassett; Apostolos Gogakos; Anna Wojcicka; Graham R Williams; Subburaman Mohan
Journal:  J Bone Miner Res       Date:  2012-05       Impact factor: 6.741

Review 9.  Mechanisms and pathways of growth failure in primordial dwarfism.

Authors:  Anna Klingseisen; Andrew P Jackson
Journal:  Genes Dev       Date:  2011-10-01       Impact factor: 11.361

10.  Corroboration of Height Velocity Prediction Markers for rhGH With an Oral GH Secretagogue Treatment in Children With GHD.

Authors:  Werner F Blum; George M Bright; Minh-Ha T Do; John C McKew; Haiying Chen; Michael O Thorner
Journal:  J Endocr Soc       Date:  2021-02-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.